Seattle biotech giant Seagen has appointed a new CEO, David Epstein, a former executive at Novartis. Epstein also…
sciencecityNovember 17, 2022
A new study shows that when an experimental cancer medication is split in half, the…
sciencecityNovember 16, 2022
Scientists for the first time have used CRISPR to substitute a gene to treat patients…
sciencecityNovember 16, 2022
Seattle biotech startup Bonum Therapeutics raised $93 million less than two months after its parent company Good…
sciencecityNovember 16, 2022
If an epilepsy patient needs brain surgery, their brain surgeon often extracts a piece of…
pthomsonNovember 15, 2022
The nearly 200-year-old phrase “you are what you eat” has some new evidence. ISB researchers…
pthomsonNovember 15, 2022
We talk to Devin Schweppe about setting up his group at the University of Washington,…
pthomsonNovember 11, 2022
Exceptional people influence one’s life choices. For Sam Regalado, those people – from Bill Nye…
sciencecityNovember 9, 2022
Today, the Access to Advanced Health Institute (AAHI) announced results from a study of their…
sciencecityNovember 8, 2022
